Recalls & alerts

171 alerts recorded, refreshed every six hours. Filter by source or category.

• openFDA · September 30, 2026Moderate risk

  Sterling Pharmaceutical Services LLC : Major LubriFresh P.M. Nighttime Ointment, Net wt. 0.125 oz. (3.5 g) tubes, Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233,…

  The recall affects Major LubriFresh P.M. Nighttime Ointment, 0.125 oz tubes, distributed by Major Pharmaceuticals. The product lacks assurance of sterility, posing a risk to consumers nationwide who use it. Consumers should stop using the ointment and return or discard it according to the recall notice.

  drugs
• openFDA · September 30, 2026Low risk

  Macleods Pharmaceuticals Limited : Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods…

  Macleods Pharmaceuticals is recalling Olanzapine Tablets, USP 5 mg, 30-count bottles, distributed nationwide in the USA. The tablets contain organic and unspecified impurities above specification, posing a risk to patients taking this medication. Consumers should stop using the affected product and contact their doctor or pharmacist for guidance.

  drugs
• openFDA · September 30, 2026Moderate risk

  Amneal Pharmaceuticals of New York, LLC : Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal…

  Amneal Pharmaceuticals is recalling Exenatide Injection, USP, 250 mcg/mL, 1.2 mL prefilled pens. The pens may have a defective delivery system and contain no medication, exposing patients to missed doses. Consumers should stop using the recalled pens and contact their pharmacist or Amneal for instructions.

  drugs
• openFDA · September 30, 2026Moderate risk

  Sterling Pharmaceutical Services LLC : Walgreens Lubricant Eye Drops, 0.5 FL OZ (15 mL) 1.0 FL OZ (30 mL) TOTAL, 2 count Twin Pack, Distributed by Walgreens Co., 200 Wilmot Road, Deerfield, IL…

  Walgreens Lubricant Eye Drops, sold as a 2-count twin pack of 0.5 FL OZ (15 mL) and 1.0 FL OZ (30 mL) bottles, are being recalled by Sterling Pharmaceutical Services. The products lack assurance of sterility, posing a risk of eye infection for consumers who use them. Consumers should stop using the recalled eye drops and return them to the store or follow the recall instructions.

  drugs
• openFDA · September 30, 2026Moderate risk

  Sterling Pharmaceutical Services LLC : Reliable -1 Laboratories, Sodium Chloride Hypertonicity Ophthalmic Solution, 5%, Sterile, 0.5 FL OZ (15 mL) bottles, Distributed by: Reliable-1 Laboratories…

  Reliable-1 Laboratories is recalling its Sodium Chloride Hypertonicity Ophthalmic Solution, 5%, Sterile, 0.5 FL OZ (15 mL) bottles. The product lacks assurance of sterility, posing a risk of eye infection to consumers who use it. Consumers should stop using the recalled solution and return it to the place of purchase or contact the firm.

  drugs
• openFDA · September 30, 2026Moderate risk

  Sterling Pharmaceutical Services LLC : Lubricant Eye Drops-Cameron Pharmaceuticals, Carboxymethylcellulose Sodium 0.5%, Eye Lubricant, 0.5 FL OZ (15 mL) bottles, Distributed by Cameron…

  Cameron Pharmaceuticals is recalling Lubricant Eye Drops, carboxymethylcellulose sodium 0.5%, in 0.5 FL OZ (15 mL) bottles. The eye drops lack assurance of sterility, posing an infection risk to consumers who use them. Consumers should stop using the recalled product and return or discard it as directed by the recall notice.

  drugs
• openFDA · September 30, 2026Moderate risk

  Sterling Pharmaceutical Services LLC : AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye Drops, Sterile, 0.5 FL OZ (15 mL) bottle, Distributed by: AVKARE, Pulaski, TN,…

  AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% lubricant eye drops, distributed by AVKARE, are recalled nationwide. The sterile eye drops lack assurance of sterility, posing a risk of infection to users. Consumers should stop using the product and follow the firm's recall instructions.

  drugs
• openFDA · September 30, 2026Moderate risk

  Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company : Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper…

  Insight Pharmaceuticals LLC is recalling Clear Eyes Redness Relief Lubricant/Redness Reliever Eye Drops, 0.5 fl oz bottles. The products lack assurance of sterility, posing a risk to consumers nationwide in the USA. Consumers should stop using the recalled eye drops and follow the firm's recall instructions.

  drugs
• openFDA · September 30, 2026Moderate risk

  Sterling Pharmaceutical Services LLC : AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye Drops, Sterile, 0.5 FL OZ (15 mL) EACH, 1.0 FL OZ (30 mL) TOTAL, 2 count Twin…

  AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5% lubricant eye drops, sold as a sterile 2-count twin pack, are affected. The product lacks assurance of sterility, posing a risk of eye infection to consumers nationwide who use these drops. Consumers should stop using the recalled eye drops and return or discard them according to the recall notice.

  drugs
• openFDA · September 30, 2026Moderate risk

  Sterling Pharmaceutical Services LLC : TRP The Relief Products* Gentle Eyes Lubricant Eye Drops, Carboxymethylcellulose sodium 0.5%, Sterile Eye Drops, 0.5 FL OZ (15 mL) bottles, Manufactured…

  Sterling Pharmaceutical Services LLC is recalling TRP The Relief Products Gentle Eyes Lubricant Eye Drops, carboxymethylcellulose sodium 0.5%, sterile eye drops in 0.5 FL OZ bottles. The eye drops lack assurance of sterility, posing a risk of infection to consumers who use them. Consumers should stop using the recalled product and return or discard it.

  drugs
• openFDA · September 23, 2026Moderate risk

  Pfizer : Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC…

  Hospira (Pfizer) is recalling Dopamine HCl Injection, USP, 200 mg/5 mL single-dose vials. The vials lack assurance of sterility, posing a risk of infection to patients who receive the injection. Consumers should stop using the recalled vials and return them to their pharmacy or healthcare provider.

  drugs
• openFDA · September 23, 2026Moderate risk

  Inventia Healthcare Limited : Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01

  Inventia Healthcare Limited's Chlorthalidone Tablets, USP, 25 mg, 100-count bottles, are affected. The tablets fail dissolution specifications, meaning they may not dissolve properly, reducing effectiveness for patients nationwide. Consumers should check their bottles for the recalled NDC and follow the recall instructions.

  drugs
• openFDA · September 23, 2026Moderate risk

  SUN PHARMA /TARO : Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist By: Taro…

  Taro Pharmaceuticals' Lidocaine Ointment USP, 5%, Spearmint Flavor, 50 g Jar, a prescription drug, is recalled. The product may fail content uniformity and assay specifications, meaning patients could receive inconsistent or incorrect doses. Consumers should stop using the recalled ointment and return it to the pharmacy or consult their healthcare provider.

  drugs
• openFDA · September 23, 2026Moderate risk

  Safecor Health, LLC : Fluphenazine HCl Elixir, USP, 2.5 mg per 5 mL, Delivers: 5 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health,…

  Safecor Health is recalling Fluphenazine HCl Elixir, USP, 2.5 mg per 5 mL, an oral elixir. The product failed stability specifications, which may reduce its effectiveness and pose a risk to patients using it. Consumers should stop using the recalled elixir and contact their pharmacist or healthcare provider for guidance.

  drugs
• openFDA · September 23, 2026Moderate risk

  Safecor Health, LLC : Fluphenazine HCl Elixir, USP, 5 mg per 1 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health,…

  Safecor Health is recalling Fluphenazine HCl Elixir, USP, 5 mg per 1 mL, 10 mL oral elixir with alcohol 14%. The product failed stability specifications, exposing patients nationwide to a potentially ineffective medication. Consumers should stop using the recalled elixir and follow Safecor Health's recall instructions.

  drugs
• openFDA · September 23, 2026Moderate risk

  Safecor Health, LLC : Fluphenazine HCl Elixir, USP, 5 mg per 10 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health,…

  Safecor Health, LLC is recalling Fluphenazine HCl Elixir, USP, 5 mg per 10 mL, an oral elixir distributed nationwide. The product failed stability specifications, which may affect its potency or safety for patients who use it. Consumers should stop using the recalled elixir and contact their pharmacist or healthcare provider for instructions.

  drugs
• openFDA · September 23, 2026High risk

  VITRUVIAS THERAPEUTICS INC : Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by:…

  Vitruvias Therapeutics is recalling Thyroid Tablets, USP, 1/2 Grain (30 mg) in 100-tablet bottles. The tablets are superpotent, meaning they contain more levothyroxine and liothyronine than stated, posing a risk of thyroid hormone overdose to patients. Consumers should stop using the recalled tablets and return them to the pharmacy or contact their healthcare provider.

  drugs
• openFDA · September 23, 2026Moderate risk

  Safecor Health, LLC : Fluphenazine HCl Elixir, USP, 10 mg per 2 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health,…

  Safecor Health, LLC is recalling Fluphenazine HCl Elixir, USP, 10 mg per 2 mL, an oral elixir distributed nationwide. The product failed stability specifications, which may affect its potency and safety for patients using it. Consumers should stop using the recalled elixir and contact their pharmacist or doctor for a replacement.

  drugs
• openFDA · September 23, 2026Moderate risk

  Safecor Health, LLC : Fluphenazine HCl Elixir, USP, 20 mg per 4 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health,…

  Safecor Health, LLC is recalling Fluphenazine HCl Elixir, USP, 20 mg per 4 mL, an oral prescription elixir. The product failed stability specifications, which may reduce its effectiveness or increase risks for patients nationwide who use it. Consumers should stop using the recalled elixir and follow the company's recall instructions.

  drugs
• openFDA · September 23, 2026Moderate risk

  Safecor Health, LLC : Fluphenazine HCl Elixir, USP, 15 mg per 3 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health,…

  Safecor Health's Fluphenazine HCl Elixir, 15 mg per 3 mL, is affected. The product failed stability specifications, exposing patients nationwide. Consumers should stop using it and follow the recall instructions.

  drugs
• openFDA · September 16, 2026High risk

  B BRAUN MEDICAL INC : 0.9% Sodium Chloride Injection, USP, 100 mL Partial Fill in 150 mL PAB Container, Sterile, Rx only, B. Braun Medical Inc., Bethlehem, PA 18018 USA, NDC…

  B. Braun Medical Inc. is recalling its 0.9% Sodium Chloride Injection, USP, 100 mL Partial Fill in 150 mL PAB Container. The sterile IV solution may contain particulate matter such as iron oxide, cellulose, or polystyrene, posing a risk to patients receiving it. Consumers should stop using the product and return it or contact B. Braun for instructions.

  drugs
• openFDA · September 16, 2026High risk

  American Regent, Inc. : Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, For Intravenous Infusion, intramuscular and Subcutaneous Use, AMERICAN…

  American Regent, Inc. is recalling Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL multiple-dose vials. The vials may contain particulate matter such as nylon, glass, and other materials, and may be broken or leaking, posing a risk of contamination and lack of sterility to patients receiving the injection. Consumers should stop using the recalled vials and return them to their pharmacy or contact their healthcare provider for guidance.

  drugs
• openFDA · September 16, 2026Moderate risk

  OurPharma LLC : fentaNYL Citrate, 1,000 mcg/100 mL (10mcg/mL) Injection solution in 100 mL, 0.9% NaCl Bag, OurPharma LLC, 2512 S. City Lake, Fayetteville, AR, NDC…

  OurPharma LLC is recalling fentaNYL Citrate injection solution in 100 mL bags. The hazard is a labeling discrepancy between the IV bag expiry and the product expiry, exposing patients to potentially expired medication. Consumers should stop using the affected product and return it to the pharmacy or contact OurPharma LLC.

  drugs
• openFDA · September 16, 2026High risk

  Baxter Healthcare Corporation : Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06

  Baxter Healthcare Corporation is recalling Dextrose Injection, USP, 70%, 2000 mL bags, a prescription drug. The solution contains stainless steel particles, posing a hazard to patients who receive the injection. Consumers should stop using the affected product and contact their healthcare provider.

  drugs
• openFDA · September 16, 2026Low risk

  Ajanta Pharma USA Inc : Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC…

  Ajanta Pharma USA Inc. is recalling Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles. The tablets failed impurity specifications, exposing patients to a slightly higher level of impurity-A. Consumers should check their bottles and contact their pharmacist or doctor for instructions.

  drugs
• openFDA · September 16, 2026Low risk

  ImprimisRx NJ LLC : Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL per dropper bottle, For Office Use Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit…

  ImprimisRx NJ LLC is recalling Povidone Iodine 1.25% and Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL dropper bottles, distributed nationwide. The product is subpotent, meaning it may not work as intended, exposing patients to inadequate disinfection or anesthesia during eye procedures. Consumers should stop using the recalled solution and return it to the place of purchase or contact the company for a refund.

  drugs
• openFDA · September 9, 2026Moderate risk

  Golden State Medical Supply Inc. : Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC: 51407-445-30.

  Golden State Medical Supply Inc. is recalling Prasugrel HCI Tablets, USP, 10mg, 30-count bottles. The tablets failed dissolution specifications, meaning they may not dissolve properly and could be less effective for patients taking this prescription drug. Consumers should stop using the recalled tablets and return them to the pharmacy or place of purchase.

  drugs
• openFDA · September 9, 2026Moderate risk

  Mylan Pharmaceuticals Inc : Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC…

  Mylan Pharmaceuticals Inc. is recalling Prasugrel Tablets, USP, 10mg, 30-count bottles, distributed nationwide in the U.S. The hazard is that the product failed dissolution specifications and 18-month stability testing. Consumers should follow the recall instructions from Mylan or the FDA.

  drugs
• openFDA · September 9, 2026Low risk

  Chiesi USA, Inc. : Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC…

  Chiesi USA, Inc. is recalling Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL, single-dose vials. The product failed stability specifications for its protein concentration profile, posing a hazard to patients who use it. Consumers should stop using the recalled product.

  drugs
• openFDA · September 9, 2026Moderate risk

  Sage Products, LLC : 2% Chlorhexidine Gluconate* Cloth, Non-sterile, 6 Disposable cloths, Sage Products LLC, 3909 Three Oaks Road, Cary, Illinois 60013. NDC: 53462-705-26

  Sage Products LLC is recalling its 2% Chlorhexidine Gluconate Cloth, Non-sterile, 6 Disposable cloths. The hazard is cross contamination with other products, affecting consumers nationwide. Consumers should check the FDA recall notice for instructions.

  drugs
• openFDA · September 9, 2026High risk

  Baxter Healthcare Corporation : 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made…

  Baxter Healthcare Corporation is recalling 0.9% Sodium Chloride Injection USP 500 mL in VIAFLEX Plastic Containers. The solution contains fiberglass particulate matter, posing a risk of injury to patients receiving the IV. Consumers should stop using the affected product and contact their healthcare provider for guidance.

  drugs
• openFDA · September 9, 2026Low risk

  American Health Packaging : Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#:…

  American Health Packaging is recalling Buprenorphine Sublingual Tablets (C-III), 2 mg, 30-count cartons. The label mix-up poses a risk to patients who may receive the wrong medication. Consumers should stop using the affected product and contact their pharmacy or American Health Packaging for return instructions.

  drugs
• openFDA · September 9, 2026High risk

  OPTIMAL BALANCE PHARMACY : Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutathione, Ascorbic Acid, Benzyl Alcohol & sterile water for injection, For IM or IV…

  Optimal Balance Pharmacy is recalling Glutathione 200 mg/mL, 30 mL sterile multidose vials for injection. The vials may contain bacterial endotoxins, posing a risk of serious infection to patients who receive the injection. Consumers should stop using the recalled vials and contact their healthcare provider or pharmacy for guidance.

  drugs
• openFDA · September 9, 2026Moderate risk

  Mylan Pharmaceuticals Inc : Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only, Manufactured for: Mylan Institutional LLC,…

  Mylan Pharmaceuticals Inc is recalling Mycophenolate Mofetil for injection, USP, 500 mg/vial, sold under the Mylan Institutional LLC label. The product fails dissolution specifications, which may affect patients receiving the injection. Consumers should contact their healthcare provider or pharmacy for guidance.

  drugs
• openFDA · September 9, 2026Moderate risk

  Baxter Healthcare Corporation : Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter…

  Baxter Healthcare Corporation is recalling Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL, in single-dose GALAXY containers. The product may be unsafe due to manufacturing quality deviations, exposing patients who receive the injection to potential harm. Consumers should stop using the recalled product and contact their healthcare provider or pharmacy for guidance.

  drugs
• openFDA · September 9, 2026Moderate risk

  Baxter Healthcare Corporation : Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Iso-osmotic, Baxter…

  Baxter Healthcare Corporation is recalling Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL, in GALAXY Single-Dose Containers. The product may be unsafe due to manufacturing quality deviations, posing a risk to patients who receive it. Consumers should stop using the recalled product and contact their healthcare provider or pharmacy for guidance.

  drugs
• openFDA · September 9, 2026Moderate risk

  Baxter Healthcare Corporation : Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by:…

  Baxter Healthcare Corporation is recalling Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL, in GALAXY 50 mL single-dose containers. The product may not be sterile due to manufacturing quality deviations, posing a risk of infection to patients receiving this injectable drug. Consumers should stop using the recalled lot and contact their healthcare provider or pharmacy for guidance.

  drugs
• openFDA · September 9, 2026Moderate risk

  Baxter Healthcare Corporation : Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare…

  Baxter Healthcare Corporation is recalling Vasopressin in 0.9% Sodium Chloride Injection, 40 units per 100 mL, 100mL single-dose containers. The product has manufacturing quality deviations, exposing patients to potential risk from the injection. Consumers should contact their healthcare provider or pharmacy for instructions on returning or replacing the product.

  drugs
• openFDA · September 9, 2026Moderate risk

  Baxter Healthcare Corporation : Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare…

  Baxter Healthcare Corporation is recalling Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL in GALAXY single-dose containers. The recall is due to current good manufacturing practice deviations, affecting patients nationwide, in Puerto Rico, and Chile. Consumers should contact their healthcare provider or pharmacy for instructions.

  drugs
• openFDA · September 9, 2026Moderate risk

  Baxter Healthcare Corporation : Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only, Sterile Nonpyrogenic, Baxter International Inc.,…

  Baxter Healthcare Corporation is recalling Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY containers. The recall is due to manufacturing deviations that may affect product quality, posing a risk to patients who receive this sterile injection. Consumers should stop using the affected product and contact their healthcare provider or pharmacy for instructions.

  drugs
• openFDA · September 9, 2026Low risk

  Bionpharma Inc. : Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottle, Rx Only, MADE IN INDIA, Distributed by: Bionpharma Inc.,…

  Bionpharma Inc. is recalling Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10 mg, 100-count bottles. The bottles may contain foreign tablets or capsules, posing a risk to consumers nationwide who have this prescription drug. Consumers should stop using the affected bottles and contact Bionpharma for return or replacement instructions.

  drugs
• openFDA · September 9, 2026Moderate risk

  Baxter Healthcare Corporation : MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC…

  Baxter Healthcare Corporation is recalling MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL. The recall is due to CGMP deviations, meaning the drug may not meet quality standards, posing a risk to patients nationwide, in Puerto Rico, and Chile. Consumers should stop using the recalled product and follow the company's recall instructions.

  drugs
• openFDA · September 9, 2026Moderate risk

  Lexia LLC : Broadway Joe's Pain Cream, 3000 gm CBD, (Histamine Dihydrochloride 0.025%) (CDB Isolate 3000mg, HempSeed Oil 2000mg),4 oz-jar, Produced for Broadway Joe's,…

  Broadway Joe's Pain Cream (3000 mg CBD, 4 oz jar) is affected. The hazard is potential contamination of raw material due to CGMP deviations, exposing consumers who bought the product in Colorado. Consumers should stop using the product and return it to the place of purchase.

  drugs
• openFDA · September 9, 2026Moderate risk

  Baxter Healthcare Corporation : Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by:…

  Baxter Healthcare Corporation is recalling Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL, in GALAXY 50 mL single-dose containers. The product may be contaminated or otherwise fail quality standards due to manufacturing deviations, posing a risk to patients who receive the injection. Consumers should stop using the recalled product and contact their healthcare provider or pharmacist for a replacement or guidance.

  drugs
• openFDA · September 9, 2026Moderate risk

  Allies Group Inc. : THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 20ml - 0.7 fl. oz. Tube, Made in the U.S.A, Distributed…

  The recall affects THE ONE SPF 50 Invisible Sunscreen Gel, distributed by Allies Group, in 20ml tubes. The product may not provide the SPF 50 protection stated on the label, exposing users to increased risk of sunburn and skin damage. Consumers should stop using the recalled sunscreen and return it to the place of purchase or contact Allies Group for a refund.

  drugs
• openFDA · September 9, 2026Moderate risk

  Baxter Healthcare Corporation : Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL (4 mcg/mL) in Galaxy 100 mL Single Dose Container, Rx only, Baxter…

  Baxter Healthcare Corporation is recalling Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL, in Galaxy 100 mL single-dose containers. The product may have manufacturing quality deviations, posing a risk to patients who receive this injection. Consumers should stop using the recalled product and contact their healthcare provider for guidance.

  drugs
• openFDA · September 9, 2026Moderate risk

  Allies Group Inc. : THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, (Avobenzone 3%, Homosalate 7%, Octocrylene 10%, Octisalate 5%), 50ML - 1.7 fl. oz Tube, Made in U.S.A, Distributed by…

  The affected product is THE ONE SPF 50 INVISIBLE SUNSCREEN GEL, distributed by Allies Group Inc., in 50ml tubes. The sunscreen may not provide the labeled SPF 50 protection, exposing users to sunburn risk. Consumers should stop using the affected product and return it to the place of purchase.

  drugs
• openFDA · September 9, 2026Moderate risk

  Baxter Healthcare Corporation : Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter healthcare…

  Baxter Healthcare Corporation is recalling Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL, in GALAXY 50 mL single-dose containers. The recall is due to manufacturing quality deviations that may affect sterility or potency, posing a risk to patients who receive this injectable drug. Patients and healthcare providers should stop using the recalled product and return it or contact Baxter for instructions.

  drugs
• openFDA · September 9, 2026Moderate risk

  Baxter Healthcare Corporation : Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Container, sterile, Nonpyrogenic, iso-osmotic solution in Dextrose, Baxter…

  Baxter Healthcare Corporation is recalling Nexterone (amiodarone HCI) 360 mg/200 mL in GALAXY Single-Dose Containers. The drug may be affected by manufacturing quality deviations, exposing patients nationwide, in Puerto Rico, and Chile to potential health risks. Consumers should stop using the product and contact their healthcare provider or pharmacy for further instructions.

  drugs
• openFDA · September 9, 2026Moderate risk

  Baxter Healthcare Corporation : Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile…

  Baxter Healthcare Corporation is recalling Daptomycin in 0.9% Sodium Chloride Injection, 500 mg per 50 mL, sold in 24-bag cartons. The recall is due to manufacturing quality deviations, which may affect sterility and pose a risk to patients receiving the injection. Consumers and healthcare providers should stop using the recalled product and follow Baxter's instructions for return or disposal.

  drugs

Data comes from official CPSC and FDA publications (United States). Summaries are generated automatically from those publications: the cited source prevails.